Previous Page  91 / 100 Next Page
Information
Show Menu
Previous Page 91 / 100 Next Page
Page Background

T

he

role

of

oxidative

stress

on

the

pathophysiology

of

metabolic

syndrome

R

ev

A

ssoc

M

ed

B

ras

2017; 63(1):85-91

85

REVIEW ARTICLE

The role of oxidative stress on the pathophysiology

of metabolic syndrome

F

abiane

V

alentini

F

rancisqueti

1

*, L

idiana

C

amargo

T

alon

C

hiaverini

2

, K

linsmann

C

arolo

dos

S

antos

1

, I

gor

O

távio

M

inatel

3

,

C

arolina

B

erchieri

R

onchi

4

, A

rtur

J

unio

T

ogneri

F

erron

5

, A

na

L

úcia

A. F

erreira

6

, C

amila

R

enata

C

orrêa

7

1

MSc, Department of Pathology, Faculdade de Medicina de Botucatu, Universidade Estadual Paulista "Júlio de Mesquita Filho" (Unesp), Botucatu, SP, Brazil

2

PhD, Department of Pathology, Faculdade de Medicina de Botucatu, Unesp, Botucatu, SP, Brazil

3

PhD, Department of Chemistry and Biochemistry, Instituto de Biociências de Botucatu, Unesp, Botucatu, SP, Brazil

4

PhD, Department of Internal Medicine, Faculdade de Medicina de Botucatu, Unesp, Botucatu, SP, Brazil

5

MSc, Department of Internal Medicine, Faculdade de Medicina de Botucatu, Unesp, Botucatu, SP, Brazil

6

MD, Adjunct Professor of the Department of Internal Medicine, Faculdade de Medicina de Botucatu, Unesp, Botucatu, SP, Brazil

7

Post-Doctorate, Lecturer in the Pathology Graduate Program, Department of Pathology, Faculdade de Medicina de Botucatu, Unesp, Botucatu, SP, Brazil

S

ummary

Study conducted at Faculdade de

Medicina de Botucatu, Universidade

Estadual Paulista "Júlio de Mesquita

Filho" (Unesp), Botucatu, SP, Brazil

Article received:

3/9/2016

Accepted for publication:

6/20/2016

*Correspondence:

Address: Av. Prof. Montenegro

Distrito de Rubião Junior, s/n

Botucatu, SP – Brazil

Postal code: 18618-970

fabianevf@gmail.com http://dx.doi.org/10.1590/1806-9282.63.01.85

Metabolic syndrome (MetS) has a high prevalence around the world. Considering

the components used to classify MetS, it is clear that it is closely related to obe-

sity. These two conditions begin with an increase in abdominal adipose tissue,

which is metabolically more active, containing a greater amount of resident

macrophages compared to other fat deposits. Abdominal adiposity promotes

inflammation and oxidative stress, which are precursors of various complications

involving MetS components, namely insulin resistance, hypertension and hy-

perlipidemia. One way to block the effects of oxidative stress would be through

the antioxidant defense system, which offsets the excess free radicals. It is known

that individuals with metabolic syndrome and obesity have high consumption

of fats and sugars originated from processed foods containing high levels of

sodium as well as low intake of fruits and vegetables, thus maintaining a state

of oxidative stress, that can speed up the onset of MetS. Healthy eating habits

could prevent or delay MetS by adding antioxidant-rich foods into the diet.

Keywords:

oxidative stress, metabolic syndrome, obesity.

I

ntroduction

Metabolic syndrome (MetS), also known as syndrome X

or insulin resistance syndrome, is characterized by the

clustering of cardiovascular risk factors such as hyperten-

sion, insulin resistance, central obesity, and atherogenic

dyslipidemia (high LDL-cholesterol, high triglycerides,

and low HDL-cholesterol).

1

MetS is a major health issue

of westernized modern societies

1

and it already appears

as one of the main challenges of current clinical practice.

In general, the International Diabetes Federation (IDF)

estimates that one-quarter of the world’s adult population

has MetS and the observed prevalence of MetS in Na-

tional Health and Nutrition Examination Survey

(NHANES) was 5% among the subjects of normal weight,

22% among the overweight, and 60% among the obese.

2

For the diagnosis of MetS, there are at least three cri-

teria based on five components: waist circumference, blood

pressure, blood glucose, triglycerides, and HDL-cholesterol.

The National Cholesterol Education Program – Adult Treat­

ment Pannel III (NCEP – ATP III)

3

adopts at least three

components for diagnosis of MetS. The IDF

4

considers the

abdominal circumference and two more components, and

the World Health Organization (WHO)

5

uses the waist/hip

ratio, presence of type 2 diabetes mellitus (DM) or insulin

resistance, microalbuminuria, hypertension and triglycerides.

Observing the components that classify the indi-

vidual as having metabolic syndrome, it can be noted that

they are all complications that commonly affect obese

individuals, which shows that there is a direct link between

these two diseases.

6

In general, these two conditions begin

to increase in abdominal adipose tissue which is more

metabolically active, containing a higher amount of res-

ident macrophages compared to other fat deposits.

7

Ab-

dominal adiposity promotes inflammation and oxidative